J, M., Z, X., BJ, T., T, B., K, X., C, L., . . . TK, P. (2021). Feasibility of improving patient's safety with in vivo dose tracking in intracavitary and interstitial HDR brachytherapy. Brachytherapy, 20(2), 353. https://doi.org/10.1016/j.brachy.2020.09.010
Chicago Style (17th ed.) CitationJ, Muenkel, Xu Z, Traughber BJ, Baig T, Xu K, Langmack C, Harris E, and Podder TK. "Feasibility of Improving Patient's Safety with In vivo Dose Tracking in Intracavitary and Interstitial HDR Brachytherapy." Brachytherapy 20, no. 2 (2021): 353. https://doi.org/10.1016/j.brachy.2020.09.010.
MLA (9th ed.) CitationJ, Muenkel, et al. "Feasibility of Improving Patient's Safety with In vivo Dose Tracking in Intracavitary and Interstitial HDR Brachytherapy." Brachytherapy, vol. 20, no. 2, 2021, p. 353, https://doi.org/10.1016/j.brachy.2020.09.010.